Skip to main content
Erschienen in: Journal of Genetic Counseling 1/2008

01.02.2008 | Original Research

Emotional Reaction to Fragile X Premutation Carrier Tests Among Infertile Women

verfasst von: Lisa M. Pastore, Wendy L. Morris, Logan B. Karns

Erschienen in: Journal of Genetic Counseling | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Female fragile X premutation carriers are at ∼10-fold increased risk of premature ovarian failure (follicle stimulating hormone >40 mIU/mL, amenorrhea, age <40). A milder degree of premature ovarian aging (diminished ovarian reserve, where follicle stimulating hormone levels are typically 10–20 mIU/mL) results in infertility. Approximately 10% of fertility clinic patients have this diagnosis. A cohort of 20 women diagnosed with diminished ovarian reserve provided a blood specimen (confidential results), and completed structured questionnaires that assessed emotional reactions to potentially being a premutation carrier (pretest questionnaire, n = 20) and the posttest known carrier status (3 month follow-up questionnaire, n = 18 non-carriers). Responses were measured using 9-point scales, and analyzed with Fisher exact and Wilcoxon exact tests. While most participants did not view fragile X premutations as a serious medical condition, perceptions of seriousness were positively correlated with anger and regret about not knowing sooner of the potential association of these premutations with infertility. Overall, when women (pretest) imagined themselves as carriers, their self-esteem and Health Orientation Scale responses were unchanged with the exception of feeling more afraid (p = 0.004). Despite strongly wishing for negative test results, they were glad to know there might be a medical explanation for their infertility.
Literatur
Zurück zum Zitat ACOG Committee on Genetics (2006). Screening for fragile X syndrome. Obstetrics & Gynecology, 107(6), 1483–1485. ACOG Committee on Genetics (2006). Screening for fragile X syndrome. Obstetrics & Gynecology, 107(6), 1483–1485.
Zurück zum Zitat Anido, A., Carlson, L. M., & Sherman, S. L. (2007). Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. Journal of Genetic Counseling, 16(1), 97–104.PubMedCrossRef Anido, A., Carlson, L. M., & Sherman, S. L. (2007). Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. Journal of Genetic Counseling, 16(1), 97–104.PubMedCrossRef
Zurück zum Zitat Anido, A., Carlson, L. M., Taft, L., & Sherman, S. (2005). Women’s attitudes toward testing for fragile X carrier status: A qualitative analysis. Journal of Genetic Counseling, 14(4), 295–306.PubMedCrossRef Anido, A., Carlson, L. M., Taft, L., & Sherman, S. (2005). Women’s attitudes toward testing for fragile X carrier status: A qualitative analysis. Journal of Genetic Counseling, 14(4), 295–306.PubMedCrossRef
Zurück zum Zitat Braat, D. D., Smits, A. P., & Thomas, C. M. (1999). Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: A pilot study. American Journal of Medical Genetics, 83, 327–328.PubMedCrossRef Braat, D. D., Smits, A. P., & Thomas, C. M. (1999). Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: A pilot study. American Journal of Medical Genetics, 83, 327–328.PubMedCrossRef
Zurück zum Zitat Brown, W. T., Houck Jr., G. E., Ding, X., Zhong, N., Nolin, S., Glicksman, A., et al. (1996). Reverse mutations in the fragile X syndrome. American Journal of Medical Genetics, 64(2), 287–292.PubMedCrossRef Brown, W. T., Houck Jr., G. E., Ding, X., Zhong, N., Nolin, S., Glicksman, A., et al. (1996). Reverse mutations in the fragile X syndrome. American Journal of Medical Genetics, 64(2), 287–292.PubMedCrossRef
Zurück zum Zitat Fisch, G. S., Snow, K., Thibodeau, S. N., Chalifaux, M., Holden, J. J., Nelson, D. L., et al. (1995). The fragile X premutation in carriers and its effect on mutation size in offspring. American Journal of Human Genetics, 56(5), 1147–1155.PubMed Fisch, G. S., Snow, K., Thibodeau, S. N., Chalifaux, M., Holden, J. J., Nelson, D. L., et al. (1995). The fragile X premutation in carriers and its effect on mutation size in offspring. American Journal of Human Genetics, 56(5), 1147–1155.PubMed
Zurück zum Zitat Greil, A. L. (1997). Infertility and psychological distress: A critical review of the literature. Social Science and Medicine, 45(11), 1679–1704.PubMedCrossRef Greil, A. L. (1997). Infertility and psychological distress: A critical review of the literature. Social Science and Medicine, 45(11), 1679–1704.PubMedCrossRef
Zurück zum Zitat Hagerman, P. J., & Hagerman, R. J. (2004). The fragile-X premutation: A maturing perspective. American Journal of Human Genetics, 74(5), 805–816 [erratum appears in am j hum genet. 2004 aug;75(2):352].PubMedCrossRef Hagerman, P. J., & Hagerman, R. J. (2004). The fragile-X premutation: A maturing perspective. American Journal of Human Genetics, 74(5), 805–816 [erratum appears in am j hum genet. 2004 aug;75(2):352].PubMedCrossRef
Zurück zum Zitat Imeson, M., & McMurray, A. (1996). Couples’ experiences of infertility: A phenomenological study. Journal of Advanced Nursing, 24(5), 1014–1022.PubMedCrossRef Imeson, M., & McMurray, A. (1996). Couples’ experiences of infertility: A phenomenological study. Journal of Advanced Nursing, 24(5), 1014–1022.PubMedCrossRef
Zurück zum Zitat Levi, A. J., Raynault, M. F., Bergh, P. A., Drews, M. R., Miller, B. T., & Scott Jr., R. T. (2001). Reproductive outcome in patients with diminished ovarian reserve. Fertility & Sterility, 76(4), 666–669.CrossRef Levi, A. J., Raynault, M. F., Bergh, P. A., Drews, M. R., Miller, B. T., & Scott Jr., R. T. (2001). Reproductive outcome in patients with diminished ovarian reserve. Fertility & Sterility, 76(4), 666–669.CrossRef
Zurück zum Zitat McConkie-Rosell, A., Abrams, L., Finucane, B., Cronister, A., Gane, L. W., Coffey, S. M., et al. (2007). Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. Journal of Genetic Counseling, in press. McConkie-Rosell, A., Abrams, L., Finucane, B., Cronister, A., Gane, L. W., Coffey, S. M., et al. (2007). Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. Journal of Genetic Counseling, in press.
Zurück zum Zitat McConkie-Rosell, A., Spiridigliozzi, G. A., Iafolla, T., Tarleton, J., & Lachiewicz, A. M. (1997). Carrier testing in the fragile X syndrome: Attitudes and opinions of obligate carriers. American Journal of Medical Genetics, 68(1), 62–69.PubMedCrossRef McConkie-Rosell, A., Spiridigliozzi, G. A., Iafolla, T., Tarleton, J., & Lachiewicz, A. M. (1997). Carrier testing in the fragile X syndrome: Attitudes and opinions of obligate carriers. American Journal of Medical Genetics, 68(1), 62–69.PubMedCrossRef
Zurück zum Zitat McConkie-Rosell, A., Spiridigliozzi, G. A., Sullivan, J. A., Dawson, D. V., & Lachiewicz, A. M. (2001). Longitudinal study of the carrier testing process for fragile X syndrome: Perceptions and coping. American Journal of Medical Genetics, 98, 37–45.PubMedCrossRef McConkie-Rosell, A., Spiridigliozzi, G. A., Sullivan, J. A., Dawson, D. V., & Lachiewicz, A. M. (2001). Longitudinal study of the carrier testing process for fragile X syndrome: Perceptions and coping. American Journal of Medical Genetics, 98, 37–45.PubMedCrossRef
Zurück zum Zitat Murray, A., Webb, J., MacSweiney, F., Shipley, E. L., Morton, N. E., & Conway, G. S. (1999). Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in fraxa premutation women. Human Reproduction, 14(5), 1217–1218.PubMedCrossRef Murray, A., Webb, J., MacSweiney, F., Shipley, E. L., Morton, N. E., & Conway, G. S. (1999). Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in fraxa premutation women. Human Reproduction, 14(5), 1217–1218.PubMedCrossRef
Zurück zum Zitat Nolin, S. L., Brown, W. T., Glicksman, A., Houck Jr., G. E., Gargano, A. D., Sullivan, A., et al. (2003). Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. American Journal of Human Genetics, 72(2), 454–464.PubMedCrossRef Nolin, S. L., Brown, W. T., Glicksman, A., Houck Jr., G. E., Gargano, A. D., Sullivan, A., et al. (2003). Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. American Journal of Human Genetics, 72(2), 454–464.PubMedCrossRef
Zurück zum Zitat Nolin, S. L., Lewis 3rd, F. A., Ye, L. L., Houck Jr., G. E., Glicksman, A. E., Limprasert, P., et al. (1996). Familial transmission of the FMR1 CGG repeat. American Journal of Human Genetics, 59(6), 1252–1261.PubMed Nolin, S. L., Lewis 3rd, F. A., Ye, L. L., Houck Jr., G. E., Glicksman, A. E., Limprasert, P., et al. (1996). Familial transmission of the FMR1 CGG repeat. American Journal of Human Genetics, 59(6), 1252–1261.PubMed
Zurück zum Zitat Pastore, L. M., Karns, L. B., Pinkerton, J. V., Silverman, L. M., Williams, C. D., & Camp, T. R. (2006). Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction. American Journal of Obstetrics and Gynecology, 194(3), 738–743.PubMedCrossRef Pastore, L. M., Karns, L. B., Pinkerton, J. V., Silverman, L. M., Williams, C. D., & Camp, T. R. (2006). Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction. American Journal of Obstetrics and Gynecology, 194(3), 738–743.PubMedCrossRef
Zurück zum Zitat Reyniers, E., Vits, L., De Boulle, K., Van Roy, B., Van Velzen, D., de Graaff, E., et al. (1993). The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nature Genetics, 4(2), 143–146.PubMedCrossRef Reyniers, E., Vits, L., De Boulle, K., Van Roy, B., Van Velzen, D., de Graaff, E., et al. (1993). The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nature Genetics, 4(2), 143–146.PubMedCrossRef
Zurück zum Zitat Rosenberg, M. (1986). Conceiving the self. Malabar, FL: Krieger. Rosenberg, M. (1986). Conceiving the self. Malabar, FL: Krieger.
Zurück zum Zitat Scott Jr., R. T., Opsahl, M. S., Leonardi, M. R., Neall, G. S., Illions, E. H., & Navot, D. (1995). Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Human Reproduction, 10(7), 1706–1710.PubMed Scott Jr., R. T., Opsahl, M. S., Leonardi, M. R., Neall, G. S., Illions, E. H., & Navot, D. (1995). Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Human Reproduction, 10(7), 1706–1710.PubMed
Zurück zum Zitat Sherman, S. L. (2000). Premature ovarian failure in the fragile X syndrome. American Journal of Medical Genetics, 97, 189–194.PubMedCrossRef Sherman, S. L. (2000). Premature ovarian failure in the fragile X syndrome. American Journal of Medical Genetics, 97, 189–194.PubMedCrossRef
Zurück zum Zitat Sherman, S., Pletcher, B. A., & Driscoll, D. A. (2005). Fragile X syndrome: Diagnostic and carrier testing. Genetics in Medicine, 7(8), 584–587.PubMedCrossRef Sherman, S., Pletcher, B. A., & Driscoll, D. A. (2005). Fragile X syndrome: Diagnostic and carrier testing. Genetics in Medicine, 7(8), 584–587.PubMedCrossRef
Zurück zum Zitat Speroff, L., & Fritz, M. A. (2005). Clinical gynecologic endocrinology and infertility (7th ed.). Philadelphia: Lippincott Williams & Wilkins. Speroff, L., & Fritz, M. A. (2005). Clinical gynecologic endocrinology and infertility (7th ed.). Philadelphia: Lippincott Williams & Wilkins.
Zurück zum Zitat Stephen, E. H., & Chandra, A. (2000). Use of infertility services in the United States: 1995. Family Planning Perspectives, 32(3), 132–137.PubMedCrossRef Stephen, E. H., & Chandra, A. (2000). Use of infertility services in the United States: 1995. Family Planning Perspectives, 32(3), 132–137.PubMedCrossRef
Zurück zum Zitat Sullivan, A. K., Marcus, M., Epstein, M. P., Allen, E. G., Anido, A. E., Paquin, J. J., et al. (2005). Association of FMR1 repeat size with ovarian dysfunction. Human Reproduction, 20(2), 402–412.PubMedCrossRef Sullivan, A. K., Marcus, M., Epstein, M. P., Allen, E. G., Anido, A. E., Paquin, J. J., et al. (2005). Association of FMR1 repeat size with ovarian dysfunction. Human Reproduction, 20(2), 402–412.PubMedCrossRef
Zurück zum Zitat Vits, L., De Boulle, K., Reyniers, E., Handig, I., Darby, J. K., Oostra, B., et al. (1994). Apparent regression of the CGG repeat in FMR1 to an allele of normal size. Human Genetics, 94(5), 523–526.PubMedCrossRef Vits, L., De Boulle, K., Reyniers, E., Handig, I., Darby, J. K., Oostra, B., et al. (1994). Apparent regression of the CGG repeat in FMR1 to an allele of normal size. Human Genetics, 94(5), 523–526.PubMedCrossRef
Zurück zum Zitat Welt, C. K., Smith, P. C., & Taylor, A. E. (2004). Evidence of early ovarian aging in fragile X premutation carriers. Journal of Clinical Endocrinology and Metabolism, 89(9), 4569–4574.PubMedCrossRef Welt, C. K., Smith, P. C., & Taylor, A. E. (2004). Evidence of early ovarian aging in fragile X premutation carriers. Journal of Clinical Endocrinology and Metabolism, 89(9), 4569–4574.PubMedCrossRef
Zurück zum Zitat Williams, J. K., & Schutte, D. L. (1997). Benefits and burdens of genetic carrier identification. Western Journal of Nursing Research, 19(1), 71–82.PubMedCrossRef Williams, J. K., & Schutte, D. L. (1997). Benefits and burdens of genetic carrier identification. Western Journal of Nursing Research, 19(1), 71–82.PubMedCrossRef
Zurück zum Zitat Wooldridge, E. Q., & Murray, R. F. J. (1988). The health orientation scale: A measure of feelings about sickle cell trait. Social Biology, 35(1–2), 126–136. Wooldridge, E. Q., & Murray, R. F. J. (1988). The health orientation scale: A measure of feelings about sickle cell trait. Social Biology, 35(1–2), 126–136.
Metadaten
Titel
Emotional Reaction to Fragile X Premutation Carrier Tests Among Infertile Women
verfasst von
Lisa M. Pastore
Wendy L. Morris
Logan B. Karns
Publikationsdatum
01.02.2008
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 1/2008
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-007-9129-9

Weitere Artikel der Ausgabe 1/2008

Journal of Genetic Counseling 1/2008 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.